Qualyst Transporter Solutions, LLC and Hepregen Execute Letter of Understanding

NORTH BETHESDA, Md.--(BUSINESS WIRE)--Qualyst Transporter Solutions, LLC and Hepregen Corporation announced today the execution of a Letter of Understanding (“LOU”) between the companies that supports a collaborative application development effort, and permits Hepregen to utilize Qualyst’s patented B-CLEAR® technology for applications involving hepatic transporter proteins in experiments to be conducted with certain key customers. This LOU also serves as a preamble to a broader partnering arrangement being negotiated between the companies, enabling the use of Hepregen’s HepatoPac™ products for routine hepatic transporter protein analysis.